Luz Marina Espina Selected Research

Venezuelan Equine Encephalomyelitis

2/2009	Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.
12/2008	[Increase of interleukin-1 beta, gamma interferon and tumor necrosis factor alpha in serum and brain of mice infected with the Venezuelan Equine Encephalitis virus].
7/2006	Melatonin decreases nitric oxide production, inducible nitric oxide synthase expression and lipid peroxidation induced by Venezuelan encephalitis equine virus in neuroblastoma cell cultures.
11/2005	In vitro, melatonin treatment decreases nitric oxide levels in murine splenocytes cultured with the venezuelan equine encephalomyelitis virus.
5/2003	Melatonin increases interleukin-1beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus.
5/2002	Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luz Marina Espina Research Topics

Disease

6	Venezuelan Equine Encephalomyelitis 02/2009 - 05/2002
5	Infections 01/2014 - 05/2002
5	Virus Diseases (Viral Diseases) 01/2014 - 05/2002
3	Dengue (Dengue Fever) 01/2010 - 12/2004
2	Asthma (Bronchial Asthma) 01/2014 - 05/2012
2	Necrosis 01/2010 - 05/2002
1	Paramyxoviridae Infections (Parainfluenza) 01/2014
1	Respiratory Syncytial Virus Infections 05/2012
1	Coinfection 01/2010
1	Fever (Fevers) 01/2010
1	Equine Encephalomyelitis (Equine Encephalitis) 07/2006
1	Neuroblastoma 07/2006
1	Body Weight (Weight, Body) 05/2003

Drug/Important Bio-Agent (IBA)

5	MelatoninIBA 02/2009 - 05/2002
4	CytokinesIBA 01/2014 - 05/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 05/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2010 - 11/2005
2	Chemokine CCL5IBA 01/2014 - 05/2012
2	ChemokinesIBA 01/2014 - 05/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014 - 05/2012
2	Interferon-gamma (Interferon, gamma)IBA 12/2008 - 05/2002
2	Interleukin-2 (IL2)IBA 12/2008 - 05/2002
2	Interleukin-4 (Interleukin 4)IBA 12/2008 - 05/2002
2	Interleukin-1beta (Interleukin 1 beta)IBA 05/2003 - 05/2002
1	Substance PIBA 05/2012
1	C-Reactive ProteinIBA 01/2010
1	Interleukin-6 (Interleukin 6)IBA 01/2010
1	luzindoleIBA 02/2009
1	SuspensionsIBA 12/2008
1	Hormones (Hormone)IBA 07/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2006
1	BilirubinIBA 06/2005
1	Transaminases (Aminotransferases)IBA 06/2005
1	Immunoglobulin G (IgG)IBA 12/2004
1	InterleukinsIBA 05/2002